Ambroxol to Slow Progression in Parkinson Disease

Summary

This is a UK only clinical trial in patients with Parkinson's disease (PD) of a drug called ambroxol hydrochloride, which is an already licensed drug for the treatment of respiratory conditions (such as a common cold) in many European countries. The aim of this trial is to find out whether ambroxol hydrochloride can slow down the progression of Parkinson's disease and to evaluate it's safety and tolerability.

Timeline

Start

2025-02-25

Primary completion

2029-02

Completion

2029-09

Drugs

Indications